CA2360795C - Therapeutic compositions containing glutathione analogs - Google Patents

Therapeutic compositions containing glutathione analogs Download PDF

Info

Publication number
CA2360795C
CA2360795C CA2360795A CA2360795A CA2360795C CA 2360795 C CA2360795 C CA 2360795C CA 2360795 A CA2360795 A CA 2360795A CA 2360795 A CA2360795 A CA 2360795A CA 2360795 C CA2360795 C CA 2360795C
Authority
CA
Canada
Prior art keywords
compound
lipid
formulation
lipid formulation
parts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA2360795A
Other languages
English (en)
French (fr)
Other versions
CA2360795A1 (en
Inventor
Thomas Redelmeier
Lawrence M. Kauvar
Robert T. Lum
Matthew H. Lyttle
Robert W. Macsata
Steven R. Schow
Hugo O. Villar
Michael R. Kozlowski
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Telik Inc
Original Assignee
Telik Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Telik Inc filed Critical Telik Inc
Publication of CA2360795A1 publication Critical patent/CA2360795A1/en
Application granted granted Critical
Publication of CA2360795C publication Critical patent/CA2360795C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A61K38/063—Glutathione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CA2360795A 1999-01-27 2000-01-27 Therapeutic compositions containing glutathione analogs Expired - Fee Related CA2360795C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US23853099A 1999-01-27 1999-01-27
US09/238,530 1999-01-27
PCT/US2000/002297 WO2000044366A2 (en) 1999-01-27 2000-01-27 Therapeutic compositions containing glutathione analogs

Publications (2)

Publication Number Publication Date
CA2360795A1 CA2360795A1 (en) 2000-08-03
CA2360795C true CA2360795C (en) 2010-03-23

Family

ID=22898312

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2360795A Expired - Fee Related CA2360795C (en) 1999-01-27 2000-01-27 Therapeutic compositions containing glutathione analogs

Country Status (12)

Country Link
EP (1) EP1143992B1 (OSRAM)
JP (2) JP2002535359A (OSRAM)
KR (1) KR100750842B1 (OSRAM)
CN (1) CN1185008C (OSRAM)
AT (1) ATE286741T1 (OSRAM)
AU (1) AU778340B2 (OSRAM)
CA (1) CA2360795C (OSRAM)
DE (1) DE60017359T2 (OSRAM)
ES (1) ES2231159T3 (OSRAM)
HK (1) HK1043310B (OSRAM)
PT (1) PT1143992E (OSRAM)
WO (1) WO2000044366A2 (OSRAM)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69925824D1 (de) 1998-04-16 2005-07-21 Teijin Ltd Glutathionderivate und dazugehörige dosisformen
US7029695B2 (en) 2001-07-10 2006-04-18 Telik, Inc. Therapeutic compositions containing glutathione analogs
DE602006003064D1 (en) 2005-01-06 2008-11-20 Telik Inc Tripeptid- und tetrapeptid-thioether
CN101434645B (zh) * 2008-12-24 2013-01-16 中国农业大学 一种合成寡肽及其用途
JP2015500809A (ja) * 2011-12-02 2015-01-08 テリク， インコーポレイテッド 非晶質エザチオスタット非溶媒和物
CN108863888B (zh) * 2018-07-18 2021-10-12 吉尔生化（上海）有限公司 一种(s)-1-(叔丁氧羰基)-5-氧吡咯烷-2-羧酸乙酯的制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5786336A (en) * 1991-04-29 1998-07-28 Terrapin Technologies, Inc. Target-selective protocols based on mimics
JP3118869B2 (ja) * 1991-05-14 2000-12-18 ウェルファイド株式会社 プロスタグランジン類含有脂肪小体組成物
CA2087902C (en) * 1992-02-05 2006-10-17 Narendra Raghunathji Desai Liposome compositions of porphyrin photosensitizers
JP3383704B2 (ja) * 1993-04-02 2003-03-04 わかもと製薬株式会社 安定なリポソーム水分散液
EP0721328A4 (en) * 1993-09-27 1997-09-17 Smithkline Beecham Corp CAMPTOTHECIN FORMULATIONS
JP2891883B2 (ja) * 1993-11-05 1999-05-17 学校法人近畿大学 抗白内障医薬組成物
DK0831877T3 (da) * 1995-06-07 2005-02-14 Telik Inc Metabolske virkninger af visse glutathionanaloge

Also Published As

Publication number Publication date
ES2231159T3 (es) 2005-05-16
AU778340B2 (en) 2004-12-02
WO2000044366A3 (en) 2000-12-21
CN1185008C (zh) 2005-01-19
HK1043310A1 (en) 2002-09-13
DE60017359T2 (de) 2005-12-01
JP2007326877A (ja) 2007-12-20
HK1043310B (zh) 2005-10-07
KR20010101775A (ko) 2001-11-14
JP2002535359A (ja) 2002-10-22
DE60017359D1 (de) 2005-02-17
EP1143992B1 (en) 2005-01-12
AU2976700A (en) 2000-08-18
WO2000044366A2 (en) 2000-08-03
EP1143992A2 (en) 2001-10-17
ATE286741T1 (de) 2005-01-15
PT1143992E (pt) 2005-05-31
CN1342084A (zh) 2002-03-27
CA2360795A1 (en) 2000-08-03
KR100750842B1 (ko) 2007-08-22

Similar Documents

Publication Publication Date Title
US7029695B2 (en) Therapeutic compositions containing glutathione analogs
JP3074733B2 (ja) 脂肪乳剤
RU2632433C2 (ru) Липидный преконцентрат с замедленным высвобождением фармакологически активного вещества и фармацевтическая композиция, содержащая его
US8765181B2 (en) Nano anticancer micelles of vinca alkaloids entrapped in polyethylene glycolylated phospholipids
CA2172110A1 (en) Pharmaceutical carriers for nanosuspensions
JPS6354684B2 (OSRAM)
JPWO1991010431A1 (ja) 脂肪乳剤
RU2571283C2 (ru) Парентеральные составы производных элацитарабина
JP2007326877A (ja) グルタチオン類縁体を含有する治療用組成物
CA2031520A1 (en) Cytochalasin compositions and therapeutic methods
ES2377352T3 (es) Nuevas composiciones a base de taxoides
US7449197B2 (en) Liposome formulation of 6,9-bis[(2-aminoethyl)-amino]benzo[g]isoquinoline-5, 10-dione dimaleate
JPH06183954A (ja) リポソーム製剤
CA2066698A1 (en) Liposomal compositions
WO1996006617A1 (en) Liposome preparation
AU2022212571A9 (en) Oral liposomal compositions
EP0348942A2 (en) Lipid membrane structures
JPWO1997048398A1 (ja) インドロカルバゾール誘導体のリポソーム製剤

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20150127